Javitt JC, Wolowacz SE, Roskell NS, Maciver F, Kelly S, Pleil AM, Zlateva GP. Cost-effectiveness of pegaptanib in age-related macular degeneration: the impact of differences between USA and UK health care systems. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006. [abstract] Value Health. 2006 Nov; 9(6):A370.
Wolowacz SE, Roskell NS, Maciver F, Kelly S. Cost-utility analysis for pegaptanib in age-related macular degeneration in the UK: the impact of demographic and disease characteristics. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006. [abstract] Value Health. 2006 Nov; 9(6):A370.
Wolowacz SE. The National Institute for Health and Clinical Excellence (NICE) Single Technology Appraisal (STA) process: an update on the first round of submissions. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 31, 2006.
Sculpher M, Longson C, Wolowacz SE, Khan S. The new National Institute of Health And Clinical Excellence (NICE) Single Technology Appraisal (STA) process: experience from the first round of completed appraisals. Poster presented at the 2006 ISPOR 9th Annual European Congress; October 28, 2006. Copenhagen, Denmark.
Sculpher M, Longson C, Wolowacz SE, Khan S. The new National Institute of Health And Clinical Excellence (NICE) Single Technology Appraisal (STA) process: experience from the first round of submissions. Poster presented at the 2006 ISPOR 11th Annual International Meeting; May 2006. Philadelphia, PA.
Longson C, Wolowacz SE, Sculpher MJ, Khan SB. The National Institute of Health and Clinical Excellence (NICE) Single Technology Appraisal (STA) process: an update on the first round of submission. Presented at the 2006 ISPOR 11th Annual International Meeting; May 2006. Philadelphia, PA.